The new vaccine factory…we transfer technology from the 5 most powerful countries in the world
Engineer Adam Al-Dabaa, CEO of the National Company that owns the first integrated vaccine manufacturing factory in Egypt, confirmed that the project represents a historic shift in the path of national and African health security, explaining that the factory will work to transfer vaccine production technology from five major countries, to be a nucleus for manufacturing 28 strategic vaccines that children and adults depend on in Egypt and the region, with investments amounting to $150 million.
Al-Dabaa said during his speech at the ceremony Laying the foundation stone for the new factory in the Suez Canal Economic Zone, he said that investing in vaccines is not a luxury, but rather a national necessity to ensure the health dignity of people, stressing that the delay that the African continent witnessed during the Covid-19 pandemic in terms of obtaining doses, despite the production of billions of vaccines globally, was a warning bell about the importance of self-reliance in the production of medicine and vaccine.
He added that the African continent still imports more than 99% of its needs for vaccines. Vaccines, and that Egypt decided to lead the change by establishing this factory, which is based on the transfer of technology from India, China, Denmark, Japan and South Korea, to be built on strong scientific foundations and global manufacturing practices, which take quality and patient safety first and foremost.
Al-Daba explained that the factory does not only target local manufacturing, but rather builds national human and technical capabilities capable of development and innovation, noting that more than 40 Egyptian experts, engineers and pharmacists have completed extensive training, within Cooperation agreements with international universities and research centers, to qualify a new generation of specialists in biovaccine technology.
He stressed that the project will contribute to creating high-level job opportunities for doctors, engineers and pharmacists, and stimulating supporting national industries such as packaging, laboratory and analysis services, which strengthens industrial value chains and turns Egypt into a regional center for manufacturing and exporting high-quality vaccines to African markets. And Arabic.
The CEO stressed that this project represents a shift in the concept of health sovereignty, saying: “If Africa really wants to advance, it cannot remain dependent on others for health. We must build our capabilities, trust our scientists, and move from being recipients to real producers.”
He pointed out that the new factory embodies the state’s vision of transferring technology internally instead of importing it ready-made, which enhances preparedness to confront potential epidemics, and raises the efficiency of the public health system in Egypt and the entire region.
Adam Al-Daba concluded his speech by thanking To the Egyptian government, to the World Health Organization, and to all the partners who supported the project, saying:
He said: We thank everyone who made this dream a national priority, and contributed to transforming the construction site into a symbol of hope, and a message that Egypt is capable of producing knowledge, not just consuming it.
This factory is one of the largest health projects in the region, and a major pillar in the state’s strategy to achieve self-sufficiency in vaccines and localize technology. Vitality.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
